Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 29/10/2026			5-day change	1st Jan Change
14.91 ^MXN	+2.90%		+1.57%	-16.66%

10-23	Genomma Lab Internacional, S.A.B. de C.V., Q3 2026 Earnings Call, Oct 22, 2026
10-21	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	14,513	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-16.94%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	18,703	18,179	17,746
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-15.91%	-2.81%	-2.38%
P/E	14.9x	12x	13.1x	11.7x	11.1x	7.66x	7.55x	6.76x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	1.03x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.4x	5.01x	0.6x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.82x	0.77x	0.73x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	1.05x	0.97x	0.89x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.61x	4.25x	3.89x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	5.05x	4.68x	4.28x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	13x	9.13x	8.26x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	7.69%	11%	12.1%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8003	1.071	1.441
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.37%	7.18%	9.66%
EPS ²	1.44	1.41	1.08	2.14	1.61	1.946	1.975	2.206
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	41.1%	54.2%	65.3%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	17,805	18,740	19,945
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,061	4,279	4,559
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,705	3,886	4,146
Net income ¹	1,451	1,397	1,031	2,137	1,607	1,951	2,058	2,285
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,190	3,666	3,233
Reference price ²	21.48	16.94	14.16	25.13	17.89	14.91	14.91	14.91
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	973,386	-	-
Announcement Date	23/2/22	22/2/23	21/2/24	26/2/25	25/2/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	7.66x	1.05x	4.61x	5.37%	772M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	28.20x	6.67x	17.93x	2.38%	417.76B
Weighted average by Cap.	36.66x	8.71x	21.54x	1.73%